Vascular biology 2014 in Monterey, California: celebrating 20 years of NAVBO by Ian W Tattersal & Henar Cuervo
VASCULAR CELL
Tattersal and Cuervo Vascular Cell 2014, 6:25
http://www.vascularcell.com/content/6/1/25MEETING REPORT Open AccessVascular biology 2014 in Monterey, California:
celebrating 20 years of NAVBO
Ian W Tattersal and Henar Cuervo*Abstract
A meeting report for Vascular Biology 2014, held in Monterey, California and organized by the North American
Vascular Biology Organization (NAVBO).
Keywords: Vascular biology, Angiogenesis, NAVBOThe North American Vascular Biology Organization
celebrated its 20th anniversary with the presentation of
Vascular Biology 2014, which took place from October 19
to 23 at the Asilomar Conference Grounds in Pacific
Grove, California. The presentations were organized into
a several concurrent thematic programs, including the
Developmental Vascular Biology and Genetics Workshop,
organized by Brant Weinstein and Brian Black, the
Vascular Inflammation Workshop, organized by Klaus Ley
and Tanya Mayadas, and a number of mini-symposia
sponsored by the Microcirculatory Society. In addition,
there were two special sessions: Vascular Therapeutics,
organized by Jan Kitajewski, and Molecular Mechanisms
Underlying the Vascular Disorder Hemorrhagic Hereditary
Telangiectasia (HHT), organized by Christopher W.C.
Hughes and co-sponsored by Cure HHT (formerly HHT
Foundation International).
With over 280 participants, 55 invited speakers, 61
selected oral presentations, and 154 posters, this meeting
brought together scientists from all over the world for a
week of intense and exciting interaction. It would be
impossible to do justice to all of the timely and insightful
presentations, but we will attempt to briefly describe some
of the notable findings that were described.
The meeting began with talks from two keynote speakers.
First, Gerald Crabtree discussed new methods and advances
in the study of chromatin regulation. He described the role
of BRG1 Associated Factors (BAFs) in the regulation of
gene expression. BAFs, also called SWI/SNFs (SWItch/
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units. The differential assembly of these subunits is associ-
ated with different cellular fate; importantly, mutations in
BAF subunits have been associated with pathological disor-
ders. Dr. Crabtree encouraged the audience to examine this
particular aspect of chromatin remodeling in the context of
vascular biology.
Next, Shaun Coughlin presented an overview of the
functions of Protease-Activated Receptors (PARs), and
provided updates on the promising preliminary results of
clinical trials of a PAR1 antagonist in the treatment of
cardiovascular disease.Vascular and immune cell interactions
A major theme of this year ? s conference was the cross-talk
between the endothelium and the immune system, and
the Vascular Inflammation Workshop contained many
interesting presentations on this subject. Catherine C.
Hedrick described the distinct behavior of a class of
patrolling monocytes, which perform a unique function in
the vasculature and can function to suppress tumor
metastasis. Gwendolyn Randolph shared the results of a
large-scale effort to genetically profile the diverse array of
resident macrophages across different tissue types. As a
highlight of this study, she described the functionality of
one example gene, Gata6, which is uniquely expressed in
peritoneal macrophages.
Luisa Iruela-Arispe spoke about the association between
macrophages and the endothelium, and in particular
discussed the role of this direct cell-cell interaction in
mediating vascular permeability. In contrast, Jason Fish,
recipient of the Springer Junior Investigator Award,
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cells can secrete microRNA-containing microvesicles,
which can be taken up by monocytes where they exert
profound immunomodulatory effects.
Developmental vascular biology and genetics
The session on vascular biology and genetics presented
many new observations that have already shaped the way
that we understand physiological blood vessel growth.
Patric Turowski shared his discovery that permeability of
the blood-brain barrier is regulated in part by polarized
expression of VEGFR1 and VEGFR2 on opposite sides of
endothelial cells. Shane Herbert described work in zebra-
fish that demonstrates the different migratory speeds of
endothelial tip and stalk cells, and their progeny, within
the developing intersomitic vessels. In an interesting twist,
Victoria Bautch amended our understanding of the classic
tip/stalk model of angiogenesis with her laboratory? s
observation that multiple cells within a single sprout can
stably adopt a tip cell-like morphology.
Molecular and cellular dynamics of angiogenesis
Veronique Gebala, who actually presented in the vascular
inflammation section, gave an exciting description of the
ways in which cytoskeletal proteins reorganize stalk cells
to induce lumen formation. Nan Qu showed us the
in vivo effects of the novel regulator of angiogenesis, Slug
(Snai2), in development and pathological angiogenesis.
Using endothelial cells isolated from a breast tumor
model, Andrew Dudley described an interesting autocrine
bFGF/TGFβ feedback loop that controls endothelial cell fate
and specification.
Hereditary hemorrhagic telangiectasia
Sponsored by Cure HHT, this session described new
advances in the search for a deeper understanding of the
pathogenesis of HHT, a genetic disease that results in
widespread arteriovenous malformations (AVMs). Using
zebrafish, Beth Roman discussed a role for crosstalk
between Notch and Alk signaling in the formation of brain
AVMs. Whitney Wooderchak-Donahue discussed work
employing deep sequencing to find novel rare mutations
that underlie a small subset of HHT cases. Returning to the
importance of immune cells in vascular biology, Paul S. Oh
described a role for macrophages in the aberrant response
to vascular insult in HHT that leads to AVM formation.
Vascular therapeutics
This year ? s new session on Vascular Therapeutics saw talks
from academic researchers as well as pharmaceutical
companies including Amgen, Eli Lily, Eisai, Genentech, and
Regeneron. They discussed a number of cutting-edge thera-
peutic and experimental techniques, from small molecule
inhibitors of angiogenic targets, to signaling pathway-activating enzymes, to high throughput methodologies for
mouse gene knockouts. This session gave attendees an
exciting glimpse into the ways in which basic science
research is translated to the clinic, and will be reprised in
next year? s meeting.
Conclusions
Presenters at NAVBO 2014 shared an enormous volume of
exciting new research, and a number of trends began to
emerge as the conference went on. Although well-known
for a long time now, the importance of understanding and
acknowledging the existence of organ-specific cell sub-
populations, and the varied and distinct mechanisms that
underlie their organization and function was frequently
addressed and emphasized. Though most cell types exhibit
this kind of heterotypic character, it is particularly import-
ant in the endothelium of different vascular beds, and in
the macrophages that contribute to context-specific angio-
genesis in these tissues.
As well as exposure to a huge array of cutting-edge
research, the attendees of NAVBO 2014 also had the
opportunity to attend a session on publication and funding,
sponsored by the Vascular Pharmacology Journal. Luisa
Iruela-Arispe gave useful tips on presenting papers to
journals, and Zorina Galis of the NHLBI discussed the
relationship between publications, successful grant applica-
tions, and faculty appointments.
To help young investigators share their research, 26 travel
awards were presented. Additionally, there were three
NAVBO meritorious Awards presented: The 2014 Judah
Folkman Award, presented to Tatiana V. Byzova, the 2014
Earl P. Benditt Award, presented to Jordan S. Pober, and the
Springer Junior Investigator Award, presented to Jason Fish.
NAVBO? s 2014 annual conference was a resounding suc-
cess, with researchers from across the globe meeting for a
week of stimulating discussion, presentation, and revelation.
We are already looking forward to the next meeting in
October, 2015, in Hyannis, Massachusetts. The 2015 meet-
ing will focus on vascular matrix biology, bioengineering,
and the biology of signaling in the cardiovascular system.
Don? t miss it!
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